STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

08.10.2012 20:08

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


1. Threadneedle Asset Management Holdings SARL

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has notified us pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4 October 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.90% (575,347 voting rights).
Threadneedle Asset Management Holdings SARL has notified us that these voting rights of 4.90% (575,347 voting rights) are attributable to Threadneedle Asset Management Holdings SARL pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings SARL inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.



2. Ameriprise Financial, Inc.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4 October 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.96% (582,627 voting rights). Ameriprise Financial, Inc. has notified us that these voting rights of 4.96% (582,627 voting rights) are attributable to Ameriprise Financial, Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


08.10.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back